keyword
https://read.qxmd.com/read/38657041/class-iia-hdac4-and-hdac7-cooperatively-regulate-gene-transcription-in-th17-cell-differentiation
#1
JOURNAL ARTICLE
Ka Lung Cheung, Li Zhao, Rajal Sharma, Anurupa Abhijit Ghosh, Michael Appiah, Yifei Sun, Anbalagan Jaganathan, Yuan Hu, Alannah LeJeune, Feihong Xu, Xinye Han, Xueting Wang, Fan Zhang, Chunyan Ren, Martin J Walsh, Huabao Xiong, Alexander Tsankov, Ming-Ming Zhou
Class II histone deacetylases (HDACs) are important in regulation of gene transcription during T cell development. However, our understanding of their cell-specific functions is limited. In this study, we reveal that class IIa Hdac4 and Hdac7 (Hdac4/7) are selectively induced in transcription, guiding the lineage-specific differentiation of mouse T-helper 17 (Th17) cells from naive CD4+ T cells. Importantly, Hdac4/7 are functionally dispensable in other Th subtypes. Mechanistically, Hdac4 interacts with the transcription factor (TF) JunB, facilitating the transcriptional activation of Th17 signature genes such as Il17a/f ...
April 30, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38656456/exploring-pyroptosis-related-signature-genes-and-potential-drugs-in-ulcerative-colitis-by-transcriptome-data-and-animal-experimental%C3%A2-validation
#2
JOURNAL ARTICLE
Yang Zhao, Yiming Ma, Jianing Pei, Xiaoxuan Zhao, Yuepeng Jiang, Qingsheng Liu
Ulcerative colitis (UC) is an idiopathic, relapsing inflammatory disorder of the colonic mucosa. Pyroptosis contributes significantly to UC. However, the molecular mechanisms of UC remain unexplained. Herein, using transcriptome data and animal experimental validation, we sought to explore pyroptosis-related molecular mechanisms, signature genes, and potential drugs in UC. Gene profiles (GSE48959, GSE59071, GSE53306, and GSE94648) were selected from the Gene Expression Omnibus (GEO) database, which contained samples derived from patients with active and inactive UC, as well as health controls...
April 24, 2024: Inflammation
https://read.qxmd.com/read/38656421/pneumocystis-jirovecii-pneumonia-complicating-use-of-upadacitinib-in-a-patient-with-ulcerative-colitis-and-primary-sclerosing-cholangitis-a-case-report
#3
JOURNAL ARTICLE
Simone Chin, Lucy Fox, Avik Majumdar, Mark Oliver, Matthew C Choy, Peter De Cruz
No abstract text is available yet for this article.
April 24, 2024: Inflammatory Bowel Diseases
https://read.qxmd.com/read/38655866/efficacy-of-dose-escalation-of-oral-5-aminosalicylic-acid-for-ulcerative-colitis-with-a-mayo-endoscopic-subscore-of-1-an-open-label-randomized-controlled-trial
#4
JOURNAL ARTICLE
Tomohiro Fukuda, Yasuhiro Aoki, Hiroki Kiyohara, Ayumi Yokoyama, Atsushi Nakazawa, Yusuke Yoshimatsu, Shinya Sugimoto, Kosaku Nanki, Yohei Mikami, Kayoko Fukuhara, Shinta Mizuno, Tomohisa Sujino, Makoto Mutaguchi, Kaoru Takabayashi, Yuichi Morohoshi, Yasuo Hosoda, Haruhiko Ogata, Yasushi Iwao, Makoto Naganuma, Takanori Kanai
BACKGROUND: Endoscopic healing is generally defined as Mayo endoscopic subscore (MES) ≤1 in ulcerative colitis (UC). However, patients with an MES of 1 are at higher relapse risk than those with an MES of 0. This study evaluated the therapeutic efficacy of proactive dose escalation of oral 5-aminosalicylic acid (5-ASA) in UC patients with an MES of 1. METHODS: An open-label, randomized controlled trial was conducted in 5 hospitals between 2018 and 2022. Ulcerative colitis patients in clinical remission under oral 5-ASA therapy and diagnosed as having an MES of 1 were enrolled...
April 24, 2024: Inflammatory Bowel Diseases
https://read.qxmd.com/read/38655853/systematic-review-and-meta-analysis-impact-of-depression-on-prognosis-in-inflammatory-bowel-disease
#5
REVIEW
Yuejin Ji, Hongxiao Li, Guoliang Dai, Xu Zhang, Wenzheng Ju
BACKGROUND AND AIM: Depression is highly prevalent in patients with inflammatory bowel disease (IBD), which may affect the prognosis of IBD. This aimed to investigate the impact of depression on prognosis in IBD. METHODS: A systematic literature search was performed in four databases (Medline, Embase, Web of Science, and PsycINFO) up to December 31, 2023. Studies were included if they investigated the impact of depression on prognosis in IBD. The primary outcome was flare in IBD, and secondary outcomes were hospitalization, readmission, emergency visits, surgery, and escalation of medical therapy...
April 24, 2024: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/38655696/nicotine-improves-dss-induced-colitis-by-inhibiting-nlrp3-and-altering-gut-microbiota
#6
JOURNAL ARTICLE
Yi-Xiang Zhang, Xiao-Qian Chi, Meng Li, Wei Zhang, Ying Guan, Lian-Qiu Wu
Ulcerative colitis (UC) is a chronic recurrent inflammatory disease affecting the rectum and colon. Numerous epidemiological studies have identified smoking as a protective factor for UC. Dysbiosis of intestinal microbiota and release of inflammatory factors are well-established characteristics associated with UC. Therefore, we have observed that nicotine exhibits the potential to ameliorate colitis symptoms in UC mice. Additionally, it exerts a regulatory effect on colonic microbiota dysbiosis by promoting the growth of beneficial bacteria while suppressing harmful bacteria...
April 24, 2024: Journal of Asian Natural Products Research
https://read.qxmd.com/read/38655181/antibiotics-influence-the-risk-of-anti-drug-antibody-formation-during-anti-tnf-therapy-in-chinese-inflammatory-bowel-disease-patients
#7
JOURNAL ARTICLE
Meng Sun, Jingyi Ju, Hongzhen Xu, Mengqi Luo, Zhaoyang Li, Yufang Wang
Aims: The formation of anti-drug antibodies (ADAs) during anti-tumor necrosis factor (anti-TNF) therapy is reported to lead to reducing serum drug levels, which may bring about a loss of response to treatment. Previous research has suggested an association between specific antibiotic classes and ADA formation during anti-TNF therapy. However, there are few studies specifically examining this association in Chinese inflammatory bowel disease (IBD) patients. Therefore, our study aimed to evaluate the possible effect of antibiotic use on ADA formation to anti-TNF therapy in Chinese patients with IBD...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38654428/dietary-factors-and-patterns-in-relation-to-risk-of-later-onset-ulcerative-colitis-in-chinese-a-prospective-study-of-0-5%C3%A2-million-people
#8
JOURNAL ARTICLE
Shuyao Song, Zhiyu Wu, Jun Lv, Canqing Yu, Dianjianyi Sun, Pei Pei, Lang Pan, Ling Yang, Yiping Chen, Huaidong Du, Lingli Chen, Dan Schmidt, Daniel Avery, Liping Duan, Junshi Chen, Zhengming Chen, Liming Li, Yuanjie Pang
BACKGROUND: There is limited evidence on the associations of dietary factors and patterns with risk of later-onset ulcerative colitis (UC) in Chinese adults. AIMS: To investigate the associations of dietary factors and patterns with risk of later-onset UC in Chinese. METHODS: The prospective China Kadoorie Biobank cohort study recruited 512,726 participants aged 30-79. Dietary habits were assessed using food frequency questionnaires. Dietary patterns were derived by factor analysis with a principal component method...
April 23, 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38653907/contributions-of-synthetic-chemicals-to-autoimmune-disease-development-and-occurrence
#9
REVIEW
Noelle N Kosarek, Emma V Preston
PURPOSE OF REVIEW: Exposure to many synthetic chemicals has been linked to a variety of adverse human health effects, including autoimmune diseases. In this scoping review, we summarize recent evidence detailing the effects of synthetic environmental chemicals on autoimmune diseases and highlight current research gaps and recommendations for future studies. RECENT FINDINGS: We identified 68 recent publications related to environmental chemical exposures and autoimmune diseases...
April 24, 2024: Current Environmental Health Reports
https://read.qxmd.com/read/38653566/safety-of-biologics-and-small-molecules-for-inflammatory-bowel-diseases-in-organ-transplant-recipients
#10
JOURNAL ARTICLE
Ga Hee Kim, Minjun Kim, Kyuwon Kim, Jung-Bin Park, Ji Eun Baek, June Hwa Bae, Seung Wook Hong, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
PURPOSE: This study aimed to evaluate the safety of biologics and small molecules for the treatment of inflammatory bowel diseases (IBD) in patients receiving antirejection therapies after organ transplants. MATERIALS AND METHODS: We reviewed the medical records of patients with IBD who received organ transplants at the Asan Medical Center between January 1989 and December 2021. We compared the parameters of patients receiving biologics or small molecules to those of patients without those therapies...
May 2024: Yonsei Medical Journal
https://read.qxmd.com/read/38653494/segmental-colectomy-in-ulcerative-colitis
#11
JOURNAL ARTICLE
Sumeyye Yilmaz, Rebecca L Gunter, Arielle E Kanters, David R Rosen, Jeremy Lipman, Stefan D Holubar, Tracy L Hull, Scott R Steele
BACKGROUND: Segmental colectomy in ulcerative colitis is performed in select patients who may be at increased risk for postoperative morbidity. OBJECTIVE: To identify ulcerative colitis patients who underwent segmental colectomy and assess their postoperative and long-term outcomes. DESIGN: Retrospective case series. SETTING: A tertiary-care inflammatory bowel disease center. PATIENTS: Ulcerative colitis patients who underwent surgery between 1995 and 2022...
April 23, 2024: Diseases of the Colon and Rectum
https://read.qxmd.com/read/38653187/huc-mscs-therapy-for-crohn-s-disease-efficacy-in-tnbs-induced-colitis-in-rats-and-pilot-clinical-study
#12
JOURNAL ARTICLE
Qinjuan Sun, Shan Li, Ritian Lin, Guangxi Zhao, Jinlai Lu, Bin Liu, Miao Hu, Wei Wang, Xiaoqing Yang, Yushuang Wei, Wenwen Jia, Yanni Hu, Wei Zhang, Jiawen Zhu, Daxiang Cui, Lan Zhong
BACKGROUND: The use of mesenchymal stem cells (MSCs) has recently emerged as a promising new therapeutic strategy for many diseases including perianal fistulizing Crohn's disease (CD). Whether hUC-MSCs can promote the healing of luminal ulcer in CD has not been studied so far. METHODS: The model of TNBS-induced colitis in rats was used to confirm the efficacy of hUC-MSCs in the treatment of CD. Then, seventeen CD patients refractory to or unsuitable for currently available therapies were enrolled and received once submucosal local injection through colonoscopy combined with once intravenous drip on the next day...
April 22, 2024: EBioMedicine
https://read.qxmd.com/read/38652966/the-histamine-h-4-receptor-antagonist-1-5-chloro-2-3-dihydro-1-benzofuran-2-yl-methyl-4-methyl-piperazine-lins01007-prevents-the-development-of-dss-induced-colitis-in-mice
#13
JOURNAL ARTICLE
Beatriz K Lippi, Gustavo A B Fernandes, Gabriela A Azevedo, Nathani G S Negreiros, Antonio W Soares, Maristella A Landgraf, João Paulo S Fernandes, Richardt G Landgraf
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with growing incidence worldwide. Our group reported the compound 5-choro-1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazine (LINS01007) as H4 R antagonist (pKi 6.2) and therefore the effects and pharmacological efficacy on a DSS-induced mice model of UC were assessed in this work. Experimental acute colitis was induced in male BALB/c mice (n = 5-10) by administering 3 % DSS in the drinking water for six days. The test compound LINS01007 was administered daily i...
April 22, 2024: International Immunopharmacology
https://read.qxmd.com/read/38652960/potential-mitigating-impact-of-a-dipeptidyl-peptidase-iv-inhibitor-vildagliptin-on-oxazolone-induced-ulcerative-colitis-targeting-the-role-of-pi3k-akt-mtor-and-ampk-nrf2-signaling-pathways
#14
JOURNAL ARTICLE
Marwa Mahmoud Awad, Rehab M El-Gohary, Sarah Ibrahim, Muhammad Tarek Abdel Ghafar, Eman E Farghal, Alshimaa Aboalsoud, Rehab Ahmed Ahmed El-Shaer
Growing evidence suggests that phosphoinositide 3-kinase (PI3K) and adenosine monophosphate-activated protein kinase (AMPK) signaling cascades are critical in ulcerative colitis (UC) pathophysiology by influencing gut mucosal inflammation. Recently, the coloprotective properties of dipeptidyl peptidase-IV (DPP-IV) inhibitors have emerged. Thus, this study assessed for the first time the potential mitigating impact of a DPP-IV inhibitor, vildagliptin (Vilda), on oxazolone (OXZ)-induced colitis in rats, targeting the role of PI3K/AKT/mTOR and AMPK/Nrf2 pathways...
April 22, 2024: International Immunopharmacology
https://read.qxmd.com/read/38652775/editorial-sequencing-rescue-therapy-for-acute-severe-ulcerative-colitis-ready-for-revision-authors-reply
#15
EDITORIAL
María José García, Javier P Gisbert, María Chaparro
No abstract text is available yet for this article.
May 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38652770/editorial-sequencing-rescue-therapy-for-acute-severe-ulcerative-colitis-ready-for-revision
#16
EDITORIAL
L A A P Derikx, F Hoentjen
No abstract text is available yet for this article.
May 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38652699/lack-of-mtorc2-signalling-in-cd11c-myeloid-cells-inhibits-their-migration-and-ameliorates-experimental-colitis
#17
JOURNAL ARTICLE
Aline Ignacio, Marcella Cipelli, Tatiane Takiishi, Cristhiane Favero Aguiar, Fernanda Fernandes Terra, Bruno Ghirotto, Eloisa Martins Silva, Angela Castoldi, Yuli Thamires Magalhães, Tiago Antonio, Barbara Nunes Padovani, Meire Ioshie Hiyane, Vinicius Andrade-Oliveira, Fabio Luis Forti, Niels Olsen Saraiva Camara
The Mammalian Target of Rapamycin (mTOR) pathway plays a key role in determining immune cells function through modulation of their metabolic status. By specific deletion of Rictor in CD11c+ myeloid cells (referred to here as CD11cRicΔ/Δ), this study investigated the role of mTOR complex 2 (mTORC2) signalling in dendritic cells (DCs) function in mice. We showed that upon DSS-induced colitis, lack of mTORC2 signalling CD11c+ cells diminishes colitis score, and abrogates dendritic cell (DC) migration to the mesenteric lymph nodes (MLN), thereby diminishing the infiltration of T helper (Th) 17 cells in the lamina propria (LP) and subsequent inflammation...
April 23, 2024: Journal of Leukocyte Biology
https://read.qxmd.com/read/38652524/intestinal-ultrasound-scan-predicts-corticosteroid-failure-and-colectomy-risk-in-patients-with-ulcerative-colitis
#18
JOURNAL ARTICLE
Baisi Yuan, Pengfei Huang, Miaofang Yang, Guoxing Tang, Fangyu Wang
OBJECTIVE: Intestinal ultrasound (IUS) is an emerging modality for assessing disease activity, extent, and treatment response in ulcerative colitis. This study aimed to evaluate the potential of IUS in predicting severe flares, the need for rescue therapy (corticosteroid failure), and colectomy in patients with ulcerative colitis. METHODS: We conducted a retrospective review of medical records, collecting clinical and IUS data. The Milan Ultrasound Criteria (MUC) score was used to assess ulcerative colitis severity...
April 17, 2024: European Journal of Gastroenterology & Hepatology
https://read.qxmd.com/read/38651786/sarm1-controls-the-myd88-mediated-inflammatory-responses-in-inflammatory-bowel-disease-via-the-regulation-of-traf3-recruitment
#19
JOURNAL ARTICLE
Huijuan Fan, Chun Song, Jingyu Zhang
BACKGROUND: Sterile alpha and TIR motif-containing 1 (Sarm1) is known as a negative regulator of inflammatory responses. However, its role in inflammatory bowel disease (IBD) is still unclear. OBJECTIVE: This study aimed to explore the function of Sarm1 in IBD and its underlying mechanisms. Sarm1 and tumor necrosis factor (TNF) receptor associated factor 3 (TRAF3) knockout (KO) micewere established. METHODS: The colitis was induced using dextran sulfate sodium (DSS)...
April 23, 2024: Immunological Investigations
https://read.qxmd.com/read/38651779/recent-steroid-use-and-the-relapse-risk-in-ulcerative-colitis-patients-with-endoscopic-healing
#20
JOURNAL ARTICLE
Tomohiro Fukuda, Hajime Yamazaki, Yusuke Miyatani, Tsunaki Sawada, Naoki Shibuya, Yuka Fukuo, Hiroki Kiyohara, Hiromu Morikubo, Keiichi Tominaga, Kazuki Kakimoto, Takayuki Imai, Katsuki Yaguchi, Shojiro Yamamoto, Katsuyoshi Ando, Nobuaki Nishimata, Takeo Yoshihara, Akira Andoh, Toshifumi Hibi, Katsuyoshi Matsuoka
BACKGROUND: Endoscopic healing (EH) is a therapeutic target in ulcerative colitis (UC). However, even patients who have achieved EH relapse frequently. AIMS: To investigate the association between recent steroid use and relapse risk in UC patients with EH. METHODS: This multi-centre cohort study included 1212 UC patients with confirmed EH (Mayo endoscopic subscore ≤1). We excluded patients with current systemic steroid use or history of advanced therapy...
April 23, 2024: Alimentary Pharmacology & Therapeutics
keyword
keyword
7016
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.